Figure S2 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Authors
Xiaofan Li (ORCID: https://orcid.org/0000-0002-4783-7372)
Figure S2 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Xiaofan Li, Millicent Embry, Cuong Tran, Gang Yin et al.
Topics
Synthesis and biological activity
article
Figure S2 from The Anti-FRα Antibody–Drug Conjugate Luveltamab Tazevibulin Demonstrates Efficacy in Non–Small Cell Lung Cancer Preclinical Models and Induces Immunogenic Cell Death
Xiaofan Li, Millicent Embry, Cuong Tran, Gang Yin, Cristina L. Abrahams, Jennifer Smith, Helena Kiefel, Alice Yam, Mark Armanini, Hans‐Peter Gerber, Genevive Hernandez, Sihong Zhou, Krishna Bajjuri, Danielle K. Lewis, Robert Yuan, Rhoneil Pena, Christine Cheng, Andrew McGeehan